19 December 2022
Cannasouth enters prospective merger arrangement with Eqalis
Cannasouth Limited (NZX:CBD) is pleased to announce that it has signed a binding term sheet (“Term Sheet”) with the Board of ...
Read More
14 December 2022
Helius first to gain THC certification in NZ
Helius Therapeutics will soon launch THC containing medicines that are both grown and made in New Zealand. Read more ...
Read More
7 December 2022
Helius achieves GACP Certification
Helius Therapeutics has received Good Agricultural and Collection Practice (GACP) certification at its purpose-built medicinal cannabis facility in East Tamaki, Auckland. ...
Read More
3 December 2022
Helius gains NZ’s first GMP certification for cannabis medicines
New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) certificate ...
Read More